title: Effect of asthma compliance enhancement training on asthma control in patients on combination therapy with salmeterol/fluticasone propionate: a randomised controlled trial.
authors.affiliation: Cardiology and Respiratory Diseases, Hvidovre Hospital, Hvidovre, Denmark. csulrik@dadlnet.dk
authors.forename: Charlotte Suppli
authors.initials: CS
authors.lastname: Ulrik
authors.forename: Birgitte Kjor
authors.initials: BK
authors.lastname: Claudius
authors.forename: Michael
authors.initials: M
authors.lastname: Tamm
authors.forename: Henrik
authors.initials: H
authors.lastname: Harving
authors.forename: Hans Christian
authors.initials: HC
authors.lastname: Siersted
authors.forename: Vibeke
authors.initials: V
authors.lastname: Backer
authors.forename: Birthe
authors.initials: B
authors.lastname: Hellquist
authors.forename: Ronald
authors.initials: R
authors.lastname: Dahl
authors.forename: Asbjørn
authors.initials: A
authors.lastname: Høgholm
authors.forename: Ida Karina
authors.initials: IK
authors.lastname: Jøhnk
mesh_terms: D000328:Adult; D000420:Albuterol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000730:Androstadienes / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D003718:Denmark; D004359:Drug Therapy, Combination; D005260:Female; D000068298:Fluticasone; D006801:Humans; D008297:Male; D010349:Patient Compliance; D000068299:Salmeterol Xinafoate; D013557:Switzerland; D016896:Treatment Outcome
chemical_list: D000730:Androstadienes; D001993:Bronchodilator Agents; D000068299:Salmeterol Xinafoate; D000068298:Fluticasone; D000420:Albuterol